Inflammation is a balanced physiological response – the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and chronic diseases. To help keep tabs on inflammation, immune cells employ a molecular machine called the NLRP3 inflammasome. NLRP3 is inactive in a healthy cell, but is switched “on” when the cell’s mitochondria (energy-generating organelles) are damaged by stress or exposure to bacterial toxins.
However, when the NLRP3 inflammasome gets stuck in the “on” position, it can contribute to a number of chronic inflammatory conditions, including gout, osteoarthritis, fatty liver disease and Alzheimer’s and Parkinson’s diseases. In a new mouse study, researchers at University of California San Diego School of Medicine discovered a unique approach that might help treat some chronic inflammatory diseases: force cells to eliminate damaged mitochondria before they activate the NLRP3 inflammasome.
The study, published April 11, 2019 by Cell Metabolism, was led by senior author Michael Karin, PhD, Distinguished Professor of Pharmacology and Pathology and Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases at UC San Diego School of Medicine, and first author Elsa Sanchez-Lopez, PhD, a senior postdoctoral researcher in Karin’s lab.
In a 2018 study published in Nature, Karin’s team had shown that damaged mitochondria activate the NLRP3 inflammasome. The researchers also found that the NLRP3 inflammasome is de-activated when mitochondria are removed by the cell’s internal waste recycling process, called mitophagy.
“After that, we wondered if we could reduce harmful excess inflammation by intentionally inducing mitophagy, which would eliminate damaged mitochondria and should in turn pre-emptively inhibit NLRP3 inflammasome activation,” Karin said. “But at the time we didn’t have a good way to induce mitophagy.”
More recently, Sanchez-Lopez was studying how macrophages regulate their uptake of choline, a nutrient critical for metabolism, when she discovered something that can initiate mitophagy: an inhibitor of the enzyme choline kinase (ChoK). With ChoK inhibited, choline is no longer incorporated into mitochondrial membranes. As a result, the cells perceive the mitochondria as damaged, and cleared them away by mitophagy.
“Most importantly, by getting rid of damaged mitochondria with ChoK inhibitors, we were finally able to inhibit NLRP3 inflammasome activation,” Karin said.
To test their new ability to control NLRP3 inflammasome in a living system, the researchers turned to mice. They discovered that treatment with ChoK inhibitors prevented acute inflammation caused by uric acid (accumulation of which triggers gout flares) and a bacterial toxin.
By several measures, ChoK inhibitor treatment also reversed chronic inflammation associated with a genetic disease called Muckle-Well Syndrome, which is caused by mutations in NLRP3 genes. One such measure is spleen size – the larger the spleen, the more inflammation. The spleens of Muckle-Well Syndrome mice are on average twice as large as normal mice, but their spleen sizes normalized after ChoK inhibitor treatment.
NLRP3 inflammasome promotes inflammation because it triggers the release of two very potent pro-inflammatory molecules called cytokines: interleukin (IL)-1? and IL-18. According to Karin, there are existing drugs that can block IL-1?, but not IL-18. ChoK inhibitors, his team found, can reduce both cytokines.
“There are several diseases, including lupus and osteoarthritis, whose treatment will likely require dual inhibition of both IL-1? and IL-18,” Karin said.
The Latest on: Chronic inflammatory disease
via Google News
The Latest on: Chronic inflammatory disease
- Chronic Fatigue Syndrome and Fibromyalgia: New Leads on May 22, 2019 at 2:43 pm
Chronic fatigue syndrome and fibromyalgia ... Our findings show clearly that it’s an inflammatory disease and provide a solid basis for a diagnostic blood test.” 2 Interestingly, one of ... […]
- Primary Care Physicians Now Have Resources to Diagnose a Rare Autoimmune Disease: Relapsing Polychondritis on May 21, 2019 at 8:00 am
About Relapsing Polychondritis Relapsing polychondritis (RP) is a systemic inflammatory disease ... advocacy and education in attacking these chronic diseases. For more information, visit https ... […]
- A Minimally Invasive Treatment for Gum Disease Now Offered by West Coast Dental -- Current Research Links Gum Disease with More Serious Diseases on May 20, 2019 at 8:00 am
Periodontitis is a chronic inflammatory disease that has been linked to other chronic illnesses, such as heart disease and diabetes. Perio Protect not only improves a patient's oral health by ... […]
- Monoclonal Antibodies Market Observing a Vibrant Growth due to the Increase in Number of Cancer Patients and Chronic Diseases on May 15, 2019 at 10:02 pm
May 16, 2019 (AmericanNewsHour via COMTEX) -- The global monoclonal antibodies market is segmented by product type into chimeric, murine, humanized, human; by production type into In vivo or In vitro; ... […]
- Gene therapy for chronic pain in dogs on May 1, 2019 at 1:08 pm
Chronic pain, either from accidents or from old age ... Osteoarthritis, also known as degenerative joint disease, is a slowly progressive inflammatory disease, which is characterized by degeneration ... […]
- Pelvic Inflammatory Disease (PID) on April 28, 2019 at 5:00 pm
Pelvic inflammatory disease (PID) is an infection of the female reproductive ... a pregnancy that occurs outside the womb chronic pelvic pain, pain in the lower abdomen caused by scarring of the ... […]
- The IL-23/IL-17 pathway in human chronic inflammatory diseases—new insight from genetics and targeted therapies on April 18, 2019 at 5:00 pm
Chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, spondyloarthritis, and psoriasis cause significant morbidity and are a considerable burden for the patients in ... […]
- Removing damaged mitochondria may relieve chronic inflammatory conditions on April 12, 2019 at 8:00 am
Researchers at UCSD have discovered a potential new way to treat chronic inflammatory diseases, by eliminating damaged mitochondria before they trigger excessive inflammation. The paper “Choline ... […]
- In mice, eliminating damaged mitochondria alleviates chronic inflammatory disease on April 11, 2019 at 2:10 pm
Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation. Inflammation is a balanced ... […]
- In mice, eliminating damaged mitochondria alleviates chronic inflammatory disease on April 11, 2019 at 12:53 pm
Inflammation is a balanced physiological response—the body needs it to eliminate invasive organisms and foreign irritants, but excessive inflammation can harm healthy cells, contributing to aging and ... […]
via Bing News